450 research outputs found
The Recommended Dose with Ray Moynihan
No full textMulti-award-winning journalist and health researcher Dr Ray Moynihan of Bond University's Centre for Research in Evidence-Based Practice (CREBP) today launched a compelling new podcast series produced by one of the world’s largest and most trusted independent health research organisations., Cochrane AustraliaThe Recommended Dose tackles the big questions in health and explores the insights, evidence and ideas of extraordinary researchers, thinkers, writers and health professionals from around the globe.Produced by Cochrane Australia and co-published with the BM
Who benefits from treating prehypertension?
No full textWith a drug company funded conference on prehypertension set to take place next year, Ray Moynihan examines the emergence of this controversial new classificatio
FDA fails to reduce accessibility of paracetamol despite 450 deaths a year
No full textConfidential documents from the US Food and Drug Administration suggest that the agency has avoided a debate on tough new measures to reduce overdoses from painkillers—to avoid offending the pharmaceutical industry. Ray Moynihan reports from Washington,
Doctors’ education: The invisible influence of drug company sponsorship
No full textAs calls to end drug companies’ direct sponsorship of doctors’ education echo round the world, an investigation in Australia reveals sponsor involvement in the education of thousands of general practitioners, writes Ray Moynihan.</p
Disease mongering is now part of the global health debate.
No full textRay Moynihan and colleagues, who organized the world's first international conference on disease mongering in 2006, discuss its subsequent impact
Selling sickness: the pharmaceutical industry and disease mongering
No full textA lot of money can be made from healthy people who believe they are sick. Pharmaceutical companies sponsor diseases and promote them to prescribers and consumers. Ray Moynihan, Iona Heath, and David Henry give examples of "disease mongering" and suggest how to prevent the growth of this practic
Interview with Susan D. Greenbaum, author, Blaming the Poor: The Long Shadow of the Moynihan Report
No full textPatrick Moynihan’s Report on the Negro Family was a seminal document in Great Society-era racial politics and public policy. Join us as we talk with Susan Greenbaum about her new book, Blaming the Poor: The Long Shadow of the Moynihan Report on Cruel Images about Poverty (Rutgers University Press, 2015), which chronicles the lasting legacy of The Moynihan Report and the ways in which housing, criminal justice, education, and poverty policy all still bear its marks
Can the relationship between doctors and drug companies ever be a healthy one?
No full textThe financial ties between doctors and drug companies have come under intense scrutiny in recent years. Some commentators--such as Marcia Angell, former editor-in-chief of the New England Journal of Medicine--argue that the mission of doctors is fundamentally different to the mission of drug companies and that the ties between them should be completely cut. "Drug companies are investor owned businesses with a responsibility to maximise profits for their shareholders," says Angell. "That is quite different from the mission of the medical profession, which is to provide the best care possible for patients." Other commentators have argued that clinicians and drug companies do have some shared goals in aiming to maximize human health. In this debate, Emma D'Arcy, co-founder of a social networking site that facilitates interactions between doctors and drug companies, argues that it would be valuable to the public if we could establish "authentic alliances" between these professionals. But journalist Ray Moynihan argues that such alliances are prone to the corrupting influence of pharmaceutical industry money, and that disentanglement is a healthier alternative
THE MOYNIHAN REPORT AND ITS AFTERMATHS
No full textAbstractThe Moynihan Report of 1965 will soon be fifty years old, and some social scientists now venerate it as a sterling application of social science data and analysis by the federal government. This author, who was directly involved in events connected with the release of the Report, does not agree; this article examines the shortcomings of the Report. I argue that Moynihan's analysis, which intended to investigate the ties between Black male unemployment and the Black family, actually devoted most of its attention to the high proportion of single-parent families in the poor Black population, treating it as one symptom of a “tangle of pathology” that stood in the way of this population's escape from joblessness and poverty. Today, the Report is being hailed as having predicted the current and still worsening state of the poor Black family. Moynihan's work is also being reinterpreted as an early application of cultural analysis, thereby further drawing attention away from the job-related issues which led Moynihan to undertake his study. Moynihan himself made significant contributions to antipoverty policy later in his career, but his Report does not deserve the worship it continues to receive.</jats:p
- …
